Reaction Details Report a problem with these data
Target
Free fatty acid receptor 1
Ligand
BDBM375106
Substrate
n/a
Meas. Tech.
IPOne assay
EC50
75.0±n/a nM
Citation
 Eckhardt, M; Wagner, H; Peters, S Indanylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof US Patent  US10253004 Publication Date 4/9/2019 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM375106
Synonyms:
US10253004, Example 20
Type:
Small organic molecule
Emp. Form.:
C28H29FN4O3
Mol. Mass.:
488.5533
SMILES:
CN(C)C(=O)c1cc(C)c(c(C)c1)-c1ccc(F)c2[C@@H](CCc12)Nc1cnc(cn1)[C@H]1C[C@@H]1C(O)=O |r,wU:30.33,19.25,wD:32.37,(-7.62,4.49,;-6.59,3.34,;-5.08,3.66,;-7.06,1.88,;-8.57,1.56,;-6.03,.73,;-6.51,-.73,;-5.48,-1.88,;-5.95,-3.34,;-3.97,-1.56,;-3.49,-.09,;-1.99,.23,;-4.52,1.05,;-2.94,-2.7,;-3.42,-4.17,;-2.38,-5.31,;-.88,-4.99,;.15,-6.13,;-.4,-3.53,;1,-2.9,;.84,-1.37,;-.66,-1.05,;-1.43,-2.38,;2.32,-3.67,;3.66,-2.9,;3.66,-1.36,;4.99,-.59,;6.32,-1.36,;6.32,-2.9,;4.99,-3.67,;7.66,-.59,;8.99,.18,;8.99,-1.36,;10.33,-.59,;11.66,-1.36,;10.33,.95,)|
Structure:
Search PDB for entries with ligand similarity: